Next-generation sequencing (NGS) identified a pathogenic mutation in the EPM2A gene (encoding laforin) on chromosome 6, confirming a diagnosis of Lafora Disease (LD) (see Figure 5). The gene discussed is EPM2A; the disease is Lafora disease.